Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7255 USD | -4.66% | -10.44% | +27.28% |
07:05pm | Oppenheimer Adjusts Price Target on Viracta Therapeutics to $11 From $13, Maintains Outperform Rating | MT |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Bullish | Neutral |
Resistance | 0.9446 | 1.170 | 1.580 |
Spread/Res. | -23.20% | -37.99% | -54.08% |
Spread/Supp. | +3.64% | +3.64% | +55.55% |
Support | 0.7000 | 0.7000 | 0.4664 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- VIRX Stock
- Charts Viracta Therapeutics, Inc.